GlaxoSmithKline Plc reported a 1% increase in turnover for the 2013 third quarter to £6.5 billion at constant exchange rates. Operating profit advanced by 1% in reported terms but on a core basis it was up by 11% to £2.1 billion. ---Subscribe to MedNous to access this article--- Company News
